Skip to main content

Biden administration backs IP waiver on covid vaccines

by Joy Green, May 6
1 minute read

The Biden administration has come out in support of waiving intellectual property protections for Covid-19 vaccines, “in service of ending this pandemic”.

person in white long sleeve shirt holding gray pen

So what

This could be a mindset shifting moment with regards to IP and public health. Historically, disastrous epidemics have been moments when big and lasting shifts have occurred in public health (such as previous advances in sanitation).

Newer teams developing vaccines are recognising the patents bottleneck on supply is unconscionable and developing more human-centred models – for example the Hexapro vaccine will allow companies and labs in 80 low- and middle-income countries to use the protein in their vaccines without paying royalties.

Could we see a long term shift to more human-centred pharma development and IP, in the name of public health?

Sources

Details

by Joy Green Spotted 27 signals

Joy is a Principal Futurist at Forum for the Future.

Have you spotted a signal of change?

Register to receive the latest from the Futures Centre.
Sign up

  • 0
  • 0
  • Share

Join discussion

Related signals

Our use of cookies

We use necessary cookies to make our site work. We'd also like to set optional analytics cookies to help us improve it. We won't set optional cookies unless you enable them. Using this tool will set a cookie on your device to remember your preferences.

For more detailed information about the cookies we use, see our Cookies page.

Necessary cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytics cookies

We'd like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our 'Cookies page'.

>